Heilongjiang case not a blot on all local govts, says NDRC official
The interference in the market activities of a private company in Heilongjiang province is an “isolated case,” and should not be used to negate the progress being made on a friendlier business environment, said an official with China’s top economic regulator.
The comments follow the accusation made by Mao Zhenhua, chairman of Sun Mountain ski resort, that the local management committee of the Northeast China province was making unpredictable administrative interferences in its operations, including asset seizures and frequent police investigation.
Mao said in a video that the management committee was not only a government institution but also a company that “uses power to edge out private
Briefly
Growth target revised slightly China’s statistics authority on Friday revised its gross domestic product (GDP) for 2016 down slightly by 0.07 percent based on its final verification. The revised GDP was 74.36 trillion yuan ($11.46 trillion), down 54.2 billion yuan from the preliminary verification, the National Bureau of Statistics said on its website. Year-on-year growth was unchanged at 6.7 percent calculated with constant prices, the statement said. Agricultural and industrial sectors were both revised up slightly, whereas the service sector was revised down by 85.6 billion yuan. companies.”
Soon after the clip went viral, personnel charged with “serious disciplinary violations” were ordered by the provincial government to tender an apology and warned of serious punishment.
Zhou Jianping, a senior official from the National Development and Reform Commission, said: “The influence of an exceptional incident should not be overstated. If a dozen or hundred of such cases happen, there must be something wrong. But if there is just one isolated case, we should not negate the works (of local governments). Punish those involved in accordance with laws. Never hurt the innocent.”
He made the remarks on Friday on the sidelines of a meeting called for revitalizing the economy of Northeast China. The region, consisting of Liaoning, Jilin and Heilongjiang provinces, was the cradle for Marketed medicine list released
The nation has released its first list of marketed medicines, with 131 types of medicine in 203 specifications, according to the China Food and Drug Administration. The list contains both generic and branded medicines, and specifies reference preparations, which offer research standards for generic medicines, a CFDA official said on Friday.
Salt industry regulation updated China has revised a regulation on common salt in an effort to reform the salt industry. The the country’s heavy industry.
The Northeast China region, though lagging behind some provinces, has been making great progress in improving the commercial environment, Zhou said.
Liu Yanqing, president of the Harbin-based Tianqing Stem Cell Co, said the biopharmaceuticals company, since its establishment in 2010, has enjoyed a lot of preferential policies and other support from the local government.
“We faced several difficulties in the registration process, because at that time the related policies were not clear for such a new industry,” Liu said. “The provincial health department organized an expert team to discuss the issue and finally we got the necessary approvals.” regulation says that provincial supervisory departments should designate salt manufacturers and wholesalers, and that salt prices should be set by operators themselves. It also abolished the mandatory management of the manufacturing, wholesaling, distribution and transportation of salt, and the procedure for salt operators to apply for permits over salt transportation. The regulation said that provincial level supervisors are responsible for government salt reserves, and designated manufacturers and wholesalers are responsible for the salt reserves of businesses.